Alpha Cf

Aconitum Napellus, Bryonia Alba Root, Eucalyptus Globulus Leaf, Eupatorium Perfoliatum Flowering Top, Gelsemium Sempervirens Root, Ipecac, Phosphorus

Schwabe Mexico, S.a. De C.v.
Human Otc Drug
NDC 68466-3398

Alpha Cf also known as Aconitum Napellus, Bryonia Alba Root, Eucalyptus Globulus Leaf, Eupatorium Perfoliatum Flowering Top, Gelsemium Sempervirens Root, Ipecac, Phosphorus is a human otc drug labeled by 'Schwabe Mexico, S.a. De C.v.'. National Drug Code (NDC) number for Alpha Cf is 68466-3398. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Alpha Cf drug includes Aconitum Napellus - 4 [hp_X]/1 Bryonia Alba Root - 4 [hp_X]/1 Eucalyptus Globulus Leaf - 2 [hp_X]/1 Eupatorium Perfoliatum Flowering Top - 6 [hp_X]/1 Gelsemium Sempervirens Root - 4 [hp_X]/1 Ipecac - 3 [hp_X]/1 Phosphorus - 6 [hp_X]/1 . The currest status of Alpha Cf drug is Active.

Drug Information:

Drug NDC:	68466-3398
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Alpha Cf
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Aconitum Napellus, Bryonia Alba Root, Eucalyptus Globulus Leaf, Eupatorium Perfoliatum Flowering Top, Gelsemium Sempervirens Root, Ipecac, Phosphorus
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Schwabe Mexico, S.a. De C.v.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ACONITUM NAPELLUS - 4 [hp_X]/1 BRYONIA ALBA ROOT - 4 [hp_X]/1 EUCALYPTUS GLOBULUS LEAF - 2 [hp_X]/1 EUPATORIUM PERFOLIATUM FLOWERING TOP - 6 [hp_X]/1 GELSEMIUM SEMPERVIRENS ROOT - 4 [hp_X]/1 IPECAC - 3 [hp_X]/1 PHOSPHORUS - 6 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	SUBLINGUAL SUBLINGUAL SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	01 Apr, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	31 Mar, 2027
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	25 Dec, 2025
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Schwabe Mexico, S.A. de C.V.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0308078033983
UPC stands for Universal Product Code.
UNII:	U0NQ8555JD T7J046YI2B S546YLW6E6 1W0775VX6E 639KR60Q1Q 62I3C8233L 27YLU75U4W
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
68466-3398-1	1 BOTTLE, GLASS in 1 BOX (68466-3398-1) / 120 TABLET in 1 BOTTLE, GLASS	01 Apr, 2017	31 Mar, 2027	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Alpha Cf

Aconitum Napellus & more..

Tablet
Schwabe Mexico, S.A. de C.V.
NDC: 68466-3398

Alpha Cf

Aconitum Napellus & more..

Tablet
Schwabe North America, Inc.
NDC: 53499-9490

Alpha Cf

Aconitum Napellus & more..

Tablet
Schwabe Mexico, S.A. de C.V.
NDC: 68466-9490

Purpose:

Purpose uses: temporarily relieves these symptoms: fever, chills, sneezing, stuffed-up nose, runny nose, coughing, sore throat, headache, minor aches and pains.

Product Elements:

Alpha cf aconitum napellus, bryonia alba root, eucalyptus globulus leaf, eupatorium perfoliatum flowering top, gelsemium sempervirens root, ipecac, phosphorus aconitum napellus aconitum napellus bryonia alba root bryonia alba root eupatorium perfoliatum flowering top eupatorium perfoliatum flowering top gelsemium sempervirens root gelsemium sempervirens root ipecac ipecac eucalyptus globulus leaf eucalyptus globulus leaf phosphorus phosphorus cellulose, microcrystalline lactose monohydrate magnesium stearate b;t bt b;t

Indications and Usage:

Indication & usage uses: temporarily relieves these symptoms: fever, chills, sneezing, stuffed-up nose, runny nose, coughing, sore throat, headache, minor aches and pains.

Warnings:

Warning sore throat warning: severe or persistent sore throat for more that 2 days or if accompanied by high fever, headache, nausea, vomiting or rash may be serious. consult a physician promptly.

Dosage and Administration:

Dosage & administration directions: sublingual medication. place tablet under tongue and let dissolve slowly. best if taken at least 15 minutes before and a half hour after eating, brushing teeth, or drinking anything except water. adults and children 12 years of age and older: at first sign of cold or flu, take 1 tablet every hour and 2 or 3 tablets before going to sleep. as symptoms subside, take 1 tablet every 2 or 3 hours. children 6 to 12 years of age: take 1/2 tablet every hour and 1 or 1 1/2 tablets before going to sleep. as symptoms subside, take 1/2 tablet every 2 or 3 hours. children under 2: ask a doctor

Stop Use:

Stop use stop use and ask a doctor if new symptoms occur, symptoms worsen or do not get better within 7 days, fever worsens or lasts more than 3 days, cough lasts more than 7 days or occurs with rash or persisitent headache. these could be signs of a serious condition.

Overdosage:

Overdosage in case of overdose, seek medical help or contact a poison control center immediately.

Package Label Principal Display Panel:

Alpha-cf_a01.jpg

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.